Autologous bone marrow mesenchymal stem cells combined with platelet-rich plasma treats knee osteoarthritis
-
摘要: 目的 探讨自体骨髓间充质干细胞复合富血小板血浆膝关节腔内注射对膝骨关节炎患者症状及关节功能的影响,为早期膝关节骨关节炎患者的治疗提供新的思路。 方法 选取2016年7月1日—2017年6月1日在六安市人民医院骨科门诊确诊为早期膝骨关节炎(Kellgren-Lawrance 0~Ⅲ级)的40例患者,采用随机数字法分为对照组和实验组,对照组膝关节腔内注射玻璃酸钠,实验组注射自体骨髓间充质干细胞复合富血小板血浆,疗程均为3次,每次间隔1个月,根据WOMAC骨关节炎评分以及VAS疼痛评分在治疗后4、12和24周对2组患者的治疗效果进行评估。 结果 治疗前2组WOMAC、VAS评分分别为38.4±14.0、5.3±1.3和38.7±12.6、5.5±1.2,差异无统计学意义(均P>0.05),治疗4、12和24周后对照组WOMAC评分分别为24.6±7.3、27.8±8.3、34.6±12.4,VAS评分分别为3.5±1.3、4.4±1.4、4.9±1.4;实验组WOMAC评分分别为19.7±4.8、21.4±5.3、24.5±8.3,VAS评分分别为3.4±1.3、3.9±1.4、4.3±1.2;2组WOMAC、VAS评分均较治疗前有明显改善(均P<0.05),且实验组治疗后各时间点的平均WOMAC评分均优于对照组(均P<0.05),2组各时间点VAS评分比较差异无统计学意义(均P>0.05)。2组有效率在治疗后12周时分别为65%、80%,差异无统计学意义(P>0.05),但在治疗后24周后实验组有效率为72%,明显优于对照组的35%(P<0.05)。 结论 膝关节腔内注射自体骨髓间充质干细胞复合富血小板血浆能够减轻膝骨关节炎患者疼痛并改善关节功能,可以作为早期膝骨关节炎患者的治疗方案之一。Abstract: Objective To investigate the effect of intra-articular injection of autologous bone marrow mesenchymal stem cells combined with platelet-rich plasma on the symptoms and joint function of patients with knee osteoarthritis in hopes of providing a new ideas for the treatment of patients with early knee osteoarthritis. Methods Forty patients diagnosed with knee osteoarthritis in the orthopedic clinic of Lu'an people' hospital from July 2016 to June 2017 were randomly divided into (intra-articular injection of sodium hyaluronate) and experimental group (intra-articular injection of autologous bone marrow mesenchymal stem cells combined with platelet-rich plasma). The treatment outcomes of the two groups were evaluated at 4, 12, and 24 weeks after treatment based on WOMAC and the VAS. Results The mean WOMAC scores of the two groups were significantly improved compared with those before treatment (all P<0.05), but the mean WOMAC scores of the experimental group at each time point after treatment were better than the control group (all P<0.05). There was no statistical difference in the mean VAS scores between the two groups (all P>0.05). The effective rate of the two groups was not significantly different at 12 weeks after treatment (P>0.05), but the effective rate of the experimental group was significantly better than that of the control group at 24 weeks after treatment (P<0.05). Conclusion Intra-articular injection of autologous bone marrow mesenchymal stem cells combined with platelet-rich plasma can alleviate pain and improve joint function in patients with knee osteoarthritis, and can be used as one of the treatment options for patients with early knee osteoarthritis.
-
Key words:
- Bone marrow mesenchymal stem cells /
- Platelet-rich plasma /
- Osteoarthritis
点击查看大图
计量
- 文章访问数: 277
- HTML全文浏览量: 76
- PDF下载量: 5
- 被引次数: 0